SQI Diagnostics (FRA:XSQ) Stock Based Compensation : €0.37 Mil (TTM As of Mar. 2023)

View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics Stock Based Compensation?

SQI Diagnostics's Stock Based Compensation for the three months ended in Mar. 2023 was €0.21 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2023 was €0.37 Mil.

SQI Diagnostics Stock Based Compensation Historical Data

The historical data trend for SQI Diagnostics's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics Stock Based Compensation Chart

SQI Diagnostics Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Stock Based Compensation

Get a 7-Day Free Trial

0.27

0.41

0.55

0.12

1.09

SQI Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Stock Based Compensation	Get a 7-Day Free Trial															0.45	0.26	-0.24	0.13	0.21

SQI Diagnostics Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.37 Mil.

SQI Diagnostics Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

SQI Diagnostics (FRA:XSQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

36 Meteor Drive, Toronto, ON, CAN, M9W 1A4

Website

https://www.sqidiagnostics.com

SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines